Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-811X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer ; volume:18 ; number:1 ; day:18 ; month:9 ; year:2020 ; pages:1-11 ; date:12.2020
Cell communication and signaling ; 18, Heft 1 (18.9.2020), 1-11, 12.2020
- Creator
-
Bahnassy, Shaymaa
Thangavel, Hariprasad
Quttina, Maram
Khan, Ashfia Fatima
Dhanyalayam, Dhanya
Ritho, Joan
Karami, Samaneh
Ren, Jing
Bawa-Khalfe, Tasneem
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-020-00649-z
- URN
-
urn:nbn:de:101:1-2020110721453497169416
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bahnassy, Shaymaa
- Thangavel, Hariprasad
- Quttina, Maram
- Khan, Ashfia Fatima
- Dhanyalayam, Dhanya
- Ritho, Joan
- Karami, Samaneh
- Ren, Jing
- Bawa-Khalfe, Tasneem
- SpringerLink (Online service)
Other Objects (12)
Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
SPDEF Regulates Fatty Acid Metabolism Driving Tumor Growth in Androgen Receptor-Positive Breast Cancer
Androgen regulation of the androgen receptor coregulators
Oestrogen receptor-negative/progesterone receptor-positive phenotype of invasive breast carcinoma in Japan: re-evaluated using immunohistochemical staining
Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes
Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer
Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor–positive breast cancers
SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer
Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
SPDEF Regulates Fatty Acid Metabolism Driving Tumor Growth in Androgen Receptor-Positive Breast Cancer
Androgen regulation of the androgen receptor coregulators
Oestrogen receptor-negative/progesterone receptor-positive phenotype of invasive breast carcinoma in Japan: re-evaluated using immunohistochemical staining
Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes
Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer
Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor–positive breast cancers
SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer
Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
SPDEF Regulates Fatty Acid Metabolism Driving Tumor Growth in Androgen Receptor-Positive Breast Cancer
Androgen regulation of the androgen receptor coregulators
Oestrogen receptor-negative/progesterone receptor-positive phenotype of invasive breast carcinoma in Japan: re-evaluated using immunohistochemical staining
Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes
Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer
Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor–positive breast cancers